Vaccine & T-cell developers

myPATHOGEN

Infectious disease target discovery — AI-guided pathogen antigen selection

Our ImmunoEngine-powered discovery pipeline myPATHOGEN is optimized for the identification of highly conserved and immunogenic epitopes across pathogen strains, combining AI-guided antigen selection, conservation analysis, immunogenicity ranking, population coverage, and translation likelihood.

What myPATHOGEN delivers

We offer an end-to-end flow with a turnaround time of 8 weeks:

  • Genome-wide association studies → linking pathogen genetic variation to phenotypes such as virulence, drug resistance, or immune evasion
  • Conservation analysis: prioritization of immunogenic epitopes within conserved regions
  • Presentation prediction: identification of surface-presented epitopes in populations infected with different strains
  • Immunogenicity prediction: identification of presented epitopes recognized by immune cells
  • myCONSTRUCT: next-generation string-of-beads design (optional)
  • myRNA: next-generation codon optimization (optional)

Frequently asked questions about myPATHOGEN

What is myPATHOGEN?

myPATHOGEN is an ImmunoEngine-powered discovery pipeline for infectious disease antigens, combining conservation analysis, immunogenicity ranking, population coverage, and translation likelihood.

What is the turnaround time for myPATHOGEN?

myPATHOGEN offers an end-to-end flow with a turnaround time of 8 weeks.

Can myPATHOGEN feed into construct design?

Yes. Optional next steps include myCONSTRUCT for string-of-beads design and myRNA for codon optimization.

Ready to use myPATHOGEN?

Talk to our team about integrating myPATHOGEN into your discovery or development workflow.